Randomized phase II trial of cetuximab with and without weekly paclitaxel in patients with previously treated advanced urothelial cancer
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Cetuximab (Primary) ; Paclitaxel (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 27 Aug 2012 Status changed from active, no longer recruiting to completed, based on results reported in the Journal of Clinical Oncology.
- 27 Aug 2012 Primary endpoint 'Progression-free-survival-duration' has been met.
- 27 Aug 2012 Results published in the Journal of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History